在当前新冠疫情期间观察到的与电压门控钾通道复合物（VGKC-complex）相关的病例增加——回应Yeo等人于2018年发表的文章《具有和不具有抗LGI1/CASPR2抗体的抗电压门控钾通道复合物血清阳性患者之间的区别》 - Suppr | 超能文献

Increased cases of VGKC-complex observed during current COVID-19 pandemic - In response to an article in 2018 "Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies" by Yeo et al.

作者信息

Vu Priscilla, Nia Saba, Saffari Pardis, Peng Davin, Liu Antonio

机构信息

Internal Medicine, Adventist Health White Memorial, Los Angeles, United States of America.

Neurology, Adventist Health White Memorial, Los Angeles, United States of America.

出版信息

J Neurol Sci. 2024 Jan 15;456:122842. doi: 10.1016/j.jns.2023.122842. Epub 2023 Dec 15.

DOI:10.1016/j.jns.2023.122842

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Increased cases of VGKC-complex observed during current COVID-19 pandemic - In response to an article in 2018 "Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies" by Yeo et al.在当前新冠疫情期间观察到的与电压门控钾通道复合物（VGKC-complex）相关的病例增加——回应Yeo等人于2018年发表的文章《具有和不具有抗LGI1/CASPR2抗体的抗电压门控钾通道复合物血清阳性患者之间的区别》

J Neurol Sci. 2024 Jan 15;456:122842. doi: 10.1016/j.jns.2023.122842. Epub 2023 Dec 15.

2

Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.抗 VGKC 复合物阳性患者中抗 LGI1/CASPR2 抗体阳性与阴性的鉴别。

J Neurol Sci. 2018 Aug 15;391:64-71. doi: 10.1016/j.jns.2018.05.020. Epub 2018 May 27.

3

From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.从 VGKC 到 LGI1 和 Caspr2 脑炎：疾病实体随时间的演变。

Autoimmun Rev. 2016 Oct;15(10):970-4. doi: 10.1016/j.autrev.2016.07.018. Epub 2016 Jul 30.

4

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.停止检测 VGKC 复合物自身抗体：仅要求检测 LGI1 和 CASPR2。

Pract Neurol. 2020 Oct;20(5):377-384. doi: 10.1136/practneurol-2019-002494. Epub 2020 Jun 28.

5

Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.抗钾通道相关蛋白复合物抗体的临床谱及诊断价值

Neurologia. 2015 Jun;30(5):295-301. doi: 10.1016/j.nrl.2013.12.007. Epub 2014 Jan 30.

6

Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).伴有抗富含亮氨酸胶质瘤失活1抗体或抗接触蛋白相关蛋白样2抗体（以前称为电压门控钾通道复合物抗体）的自身免疫性脑炎。

Curr Opin Neurol. 2017 Jun;30(3):302-309. doi: 10.1097/WCO.0000000000000444.

7

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.在缺乏LGI1和Caspr2抗体的情况下VGKC阳性的相关性。

Neurology. 2016 May 3;86(18):1692-9. doi: 10.1212/WNL.0000000000002637. Epub 2016 Apr 1.

8

Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels.采用基于细胞的商业检测法检测VGKC复合抗体水平极高的患者体内的LGI1和CASPR2抗体。

J Neurol Sci. 2017 Jul 15;378:85-90. doi: 10.1016/j.jns.2017.04.045. Epub 2017 Apr 28.

9

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.LGI1 和 CASPR2 钾通道复合物自身抗体亚型的研究进展。

JAMA Neurol. 2013 Feb;70(2):229-34. doi: 10.1001/jamaneurol.2013.592.

10

[Voltage-Gated Potassium Channels (VGKC) Complex-Associated Disorders: Anti-LGI1 Encephalitis and Anti-Caspr2 Encephalitis].[电压门控钾通道（VGKC）复合物相关疾病：抗LGI1脑炎和抗Caspr2脑炎]

Brain Nerve. 2023 Jun;75(6):721-727. doi: 10.11477/mf.1416202407.

引用本文的文献

1

Advancing Parkinson's diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples.推进帕金森病诊断：用于在微创样本中检测α-突触核蛋白的种子扩增检测法。

Mol Cell Biochem. 2025 Jun;480(6):3297-3314. doi: 10.1007/s11010-024-05190-y. Epub 2025 Jan 6.